The store will not work correctly when cookies are disabled.
SODIUM ARSENITE
ID: ALA1909078
Max Phase: Preclinical
Molecular Formula: AsNaO2
Molecular Weight: 107.93
Molecule Type: Small molecule
Associated Items:
Representations
Synonyms (1): Sodium Arsenite
Synonyms from Alternative Forms(1):
Canonical SMILES: O=[As][O-].[Na+]
Standard InChI: InChI=1S/AsHO2.Na/c2-1-3;/h(H,2,3);/q;+1/p-1
Standard InChI Key: PTLRDCMBXHILCL-UHFFFAOYSA-M
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Properties
Molecular Weight: 107.93 | Molecular Weight (Monoisotopic): 107.9193 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
References
1. Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program. DrugMatrix in vitro pharmacology data, |
2. DrugMatrix, [10.6019/CHEMBL3885881] |